检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]广东药学院 广东省药物新剂型重点实验室,广州市510006
出 处:《中国药房》2010年第17期1584-1587,共4页China Pharmacy
摘 要:目的:制备盐酸罗沙替丁脉冲控释微丸(ROXPCP)。方法:取空白丸芯分别以含药层、溶胀层(含交联羧甲基纤维素钠)和控释层(含乙基纤维素水分散体)顺序包衣制备ROXPCP,通过考察不同类型空白丸芯、溶胀层材料及溶胀层与控释层的不同包衣增重对药物释放的影响来优选工艺,并进行处方验证试验。结果:各考察因素均对药物的释放影响显著。优选工艺结果为:空白丸芯采用蔗糖型,溶胀层材料采用交联羧甲基纤维素钠,溶胀层和控释层包衣增重分别为15%、24%。以此制备的微丸时滞时间为4h左右,时滞后4h内累积释药百分率达到80%。结论:所制备的ROXPCP具有体外脉冲控释作用。OBJECTIVE: To prepare the roxatidine aidcetic hydrochloride pulsatile controlled-release pellets (ROXPCP). METHODS: Blank core were coated with Roxatidine aidcetic hydrochloride (ROX) as drug-containing layer, swelling agent containing croscarmellose sodium and controlled-release layer containing ethylcellulose aqueous dispersion respectively to prepare ROXPCP. The effects of the materials of blank core and swelling layer, the weight of swelling layer and controlled-release layer on the release of ROX were investigated to optimize process technology and validate formula. RESULTS: The release behavior was influenced strikingly by the types and weight of coating layer. The optimal formula was as follows: ROXPCP were prepared using croscarmellose sodium as inner layer with 15% (weight) coating level and ethylcellulose aqueous dispersion (surelease) as outer controlled-release layer with 24% (weight) coating level. The lag time of prepared pellets was about 4 h and accumulative release rate reached 80% within 4 h. CONCLUSIONS: The drug release of ROXPCP was shown in pulsatile way in vitro.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249